Skip to main content
Laura B. Amsden on Muck Rack

Laura B. Amsden

As seen in: PLOS ONE, BMJ Open
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Laura B.

Contact Laura B., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey

|
By Mariah Wood, Jeanne Bertolli, Laura B. Amsden, Nicole Halmer
| PLOS ONE
Citation: Wood MS, Halmer N, Bertolli J, Amsden LB, Nugent JR, Lin J-MS, et al. (2024) Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey. PLoS ONE 19(9): e0309810.
Open in Who Shared Issue with article?

Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19

|
By Jacek Skarbinski, Liyan Liu, Vennis Hong, Laura B. Amsden
| BMJ Open Verified
Discussion In this study of 4185 mechanically ventilated patients with COVID-19 hospitalised in 36 hospitals in a large integrated health system in California, USA, patients treated with tocilizumab in the first 10 days after initiation of mechanical ventilation had a similar risk of death within 28 days compared with non-tocilizumab-treated patients, but had a significantly longer time-to-extubation from mechanical ventilation and longer time-to-hospital discharge.
Open in Who Shared View Duplicates (2) Issue with article?

Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment | JCO Clinical Cancer Informatics

|
By Andrea L. Harzstark, Andrea Altschuler, Laura B. Amsden, Mubarika Alavi
| ascopubs.org
PURPOSE In 2016, Kaiser Permanente Northern California began regionalizing testicular cancer care using population-based tumor board review. This mixed methods evaluation describes implementation outcomes and learnings. METHODS We conducted in-depth interviews with key stakeholders, administered surveys to local oncologists and urologists, and used clinical data to evaluate changes in care delivery during 2015-2018. RESULTS An average of 135 patients with testicular cancer were diagnosed each year.
Open in Who Shared Issue with article?
See all 3 articles